At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
Receive Blood Volume Analysis Guided Treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Blood Volume Analysis - Guided Heart Failure Management
In Brief
A clinical study evaluating Receive Blood Volume Analysis Guided Treatment for Heart Failure and Congestive Heart Failure. Completed, enrolled 31 participants across 1 site.
Detailed Summary
The purpose of this study is to better understand blood volume status and whether knowledge of it can change and improve heart failure care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Congestive Heart Failure
CountriesUnited States
CollaboratorsDaxor Corporation
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartJul 2020
Primary CompletionJul 2021
Study CompletionSep 2021
TodayJul 2026
First PostedOct 1, 2019
Enrollment StartJul 16, 2020
Primary CompletionJul 15, 2021
Study CompletionSep 23, 2021
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.8 years ago
Interventions
Receive Blood Volume Analysis Guided Treatmentdevice
The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis